NASHVILLE, TN / ACCESSWIRE / February 22, 2021 / EV Biologics Corp, (OTC PINK:YECO), today announced that during its Q1 R&D meeting, the executive board reviewed and has approved a plan for cGMP ...

Dublin, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Manufacturing Process Validation (Nov 17th - Nov 18th, 2025)" training has been added to ResearchAndMarkets.com's offering. This ...

Raman spectroscopy has proven its ability to accurately detect subtle changes in complex aqueous systems, greatly broadening its application scope, including monitoring biopharmaceutical processes ...

GEN: Your company maintains that the supply chain of single-use assemblies is the biggest bottleneck in biopharmaceutical manufacturing. Can you talk about why that is the case and how you address ...

The biopharmaceutical process analytical technology market is projected to grow at a CAGR of ~16% over the forecast period. Major factors driving growth include increased demand for biopharmaceuticals ...

The biopharmaceutical process analytical technology market is projected to grow at a CAGR of ~16% over the forecast period. Major factors driving growth include increased demand for biopharmaceuticals ...

Biopharmaceutical process analytical technology offers growth by enhancing drug development efficiency, regulatory compliance ...

Dublin, Dec. 13, 2024 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Process Analytical Technology Market by Product, Technology, Application, End-users and Region - Global Forecast 2025-2030" report has ...

In process monitoring is important for optimizing cell culture conditions such as nutrient concentrations, cell viability, and metabolite production as well as product quality attributes such as ...

insights from industryJason Lin Ph.D.Application ScientistWyatt Technology In this interview, Jason Lin Ph.D. Application Scientist from Wyatt Technology, talks to News-Medical about the new ultraDAWN ...

TOKYO--(BUSINESS WIRE)--FUJIFILM Corporation (President: Kenji Sukeno) is to invest a total of 3.2 billion yen on its CDMO *1 sites in the U.S.A. and the U.K. in order to accelerate the expansion of ...

(MENAFN- GlobeNewsWire - Nasdaq) This training session presents opportunities in enhancing compliance and efficiency in drug manufacturing by deepening understanding of FDA and EU guidelines, ...